Day: September 8, 2022

Endexx Significantly Expands Distribution Network and Revenue Through Acquisition of Controlling Interest in Non-Nicotine Vape Producer, Hyla

Written by Customer Service on September 8, 2022. Posted in Public Companies.

Endexx Corporation Endexx Acquires HylaHyla Maintains International Distribution in 10 Countries, Including at Internationally Renowned UK Department Store, Harrods CAVE CREEK, Ariz., Sept. 08, 2022 (GLOBE NEWSWIRE) — via NewMediaWire – Endexx Corporation (OTC:EDXC), a provider of innovative, plant-based, and sustainable health and skincare products, today announces the acquisition of a controlling interest in Hyla US Holdco Limited, a producer and distributor of organic, plant-based, all-natural, zero-nicotine vape products. The acquisition provides two key benefits to Endexx in the near term:an expanded international distribution network in 10 countries – Dubai, Saudi Arabia, the United Kingdom, the Czech Republic, Slovakia, Germany, France, the Kingdom of Bahrain, Egypt, and Switzerland, which Endexx expects will...

Uponor Infra Oy and Uponor Suomi Oy deny the claims of the Finnish Competition and Consumer Authority regarding the breaches of Competition Act

Written by Customer Service on September 8, 2022. Posted in Public Companies.

Uponor Corporation, Inside information, 8 September 2022 at 12:30 EEST Uponor Infra Oy and Uponor Suomi Oy deny the claims of the Finnish Competition and Consumer Authority regarding the breaches of Competition Act Uponor Corporation has today received information that the Finnish Competition and Consumer Authority (FCCA) will propose that the Market Court would impose competition infringement fines to its subsidiaries Uponor Infra Oy (EUR 8.5 million) and Uponor Suomi Oy (EUR 5 million) concerning alleged violations of the Competition Act. According to the proposal of the FCCA, Uponor along with other operators in the sector have violated the Competition Act by dividing markets and restricting price competition between the parties in plastic HVAC infrastructure plumbing markets in Finland between the years 2009–2016. Uponor deems the...

Correction: PCI Biotech: Mandatory notification regarding trade of shares

Written by Customer Service on September 8, 2022. Posted in Public Companies.

Borkenholm AS has on 8 September 2022 purchased 4,000 shares in PCI Biotech Holding ASA (“PCI Biotech”) at an average price of NOK 1.948 per share. Borkenholm AS is a related party to board member Hilde Furberg. After the transaction, Hilde Furberg and her related parties holds 8,000 shares in PCI Biotech. Release updated with attachment. This information is subject to the disclosure requirements in MAR (regulation (EU) No. 596/2014 on market abuse) as implemented in Norway in accordance with section 3-1 of the Securities Trading Act. AttachmentSkjema for melding om transaksjoner Borkenholm AS 08092022

Rule 8.3 – GB Group Plc

Written by Customer Service on September 8, 2022. Posted in Mergers And Acquisitions.

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Investec Wealth & Investment Limited(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.N/A(c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offereeGB Group Plc(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e) Date...

Rule 8.3 – Next Fifteen Communications

Written by Customer Service on September 8, 2022. Posted in Mergers And Acquisitions.

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Investec Wealth & Investment Limited(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.N/A(c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offereeNext Fifteen Communications(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:...

INISSION AB COMMENCES ITS MANDATORY PUBLIC TENDER OFFER FOR ALL SHARES IN ENEDO PLC

Written by Customer Service on September 8, 2022. Posted in Public Companies.

Enedo Plc / Stock Exchange Release 8 September 2022 at 12:15 INISSION AB COMMENCES ITS MANDATORY PUBLIC TENDER OFFER FOR ALL SHARES IN ENEDO PLC Not to be published or distributed, directly or indirectly, in Australia, Canada, China, Hong Kong, Japan, New Zealand, Singapore, South Africa or in the United States or in any other jurisdiction where prohibited by applicable law. Inission AB, a North European contract manufacturer listed on Nasdaq First North Growth Market Stockholm, has on July 1, 2022, notified that Inission AB has increased the ownership in Enedo to 80,43%. Inission AB has also earlier on August 1, 2022, notified that it has published the Mandatory public tender offer for all shares in Enedo Plc. Inission AB has today notified that it commences its Mandatory public tender offer for all shares in Enedo Plc. More information...

PCI Biotech: Mandatory notification regarding trade of shares

Written by Customer Service on September 8, 2022. Posted in Public Companies.

Borkenholm AS has on 8 September 2022 purchased 4,000 shares in PCI Biotech Holding ASA (“PCI Biotech”) at an average price of NOK 1.948 per share. Borkenholm AS is a related party to board member Hilde Furberg. After the transaction, Hilde Furberg and her related parties holds 8,000 shares in PCI Biotech. This information is subject to the disclosure requirements pursuant to section 4-2 of the Norwegian Securities Trading Act.

Burning Rock Announces Results of 2022 Annual General Meeting

Written by Customer Service on September 8, 2022. Posted in Public Companies.

GUANGZHOU, China, Sept. 08, 2022 (GLOBE NEWSWIRE) — Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”), a company focusing on the application of next generation sequencing (NGS) technology in the field of precision oncology, today announced that all shareholder resolutions proposed at the Company’s 2022 annual general meeting held today were duly passed. Specifically, the shareholders passed the following resolutions approving:the ratification of the appointment of Ernst & Young Hua Ming LLP as auditor of the Company for the fiscal year ending December 31, 2022 and the authorization for the directors of the Company to determine the remuneration of the auditor; the re-election of Feng Deng, Leo Li and Licen Lisa Xu as directors of the Company; the approval, confirmation and ratification of the adoption...

Capgemini acquires Knowledge Expert SA

Written by Customer Service on September 8, 2022. Posted in Mergers And Acquisitions.

Media relations:Sam ConnattyTel.: +44 (0)370 904 3601 sam.connatty@capgemini.com Investor relations:Vincent BiraudTel.: +33 1 47 54 50 87vincent.biraud@capgemini.com Capgemini acquires Knowledge Expert SA Acquisition will help enhance the footprint of digital customer experience transformation services across Europe Paris, September 8, 2022 – Capgemini announced today that it has acquired Knowledge Expert SA, a digital transformation service provider specializing in Pega technologies. The acquisition will enhance Capgemini’s capabilities in its digital customer experience offerings across Europe. Headquartered in Geneva, Knowledge Expert (KE)’s team is located mainly in Europe. As a registered Pega Service Partner, KE experts use this low-code scalable architecture1 to help its clients transform their digital strategies into market realities...

Biolog-id and Genesis Growth Tech Acquisition Corp. Announce Execution of Business Combination Agreement for Proposed Merger to Create Publicly Listed Digital Health Solutions Company Focused on Value Chain Optimization

Written by Customer Service on September 8, 2022. Posted in Mergers And Acquisitions.

Anticipated Cash Resources to be used to Advance Biolog-id Value Chain Optimization Platform for Blood Products and other Biologics BERNAY, France and NIDWALDEN, Switzerland, Sept. 08, 2022 (GLOBE NEWSWIRE) — Biolog-id, a digital health solution provider focusing on value-chain optimization, and Genesis Growth Tech Acquisition Corp. (Nasdaq: GGAA) (“GGAA” or “Genesis”), a special purpose acquisition company, have executed the business combination agreement (the “BCA”) in relation to their proposed merger. The boards of directors of both Biolog-id and Genesis have unanimously approved the BCA. “It took creativity, patience, and persistence to take Biolog-id from an innovative idea to a functioning solution to a viable global business,” said Jean-Claude Mongrenier, founder, shareholder, and Chairman of the Biolog-id Board...

M	T	W	T	F	S	S
			1	2	3	4
5	6	7	8	9	10	11
12	13	14	15	16	17	18
19	20	21	22	23	24	25
26	27	28	29	30

Day: September 8, 2022

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals